Enbrel and Mean cell haemoglobin concentration decreased - a phase IV clinical study of FDA data

Summary:

Mean cell haemoglobin concentration decreased is reported as a side effect among people who take Enbrel (etanercept), especially for people who are female, 60+ old, have been taking the drug for 5 - 10 years also take Arava, and have Psoriasis.

The phase IV clinical study analyzes which people have Mean cell haemoglobin concentration decreased when taking Enbrel. It is created by eHealthMe based on reports of 662,905 people who have side effects when taking Enbrel from the FDA, and is updated regularly.

What is Enbrel?

Enbrel has active ingredients of etanercept. It is often used in rheumatoid arthritis. eHealthMe is studying from 664,678 Enbrel users. Check the latest studies of Enbrel.

What is Mean cell haemoglobin concentration decreased?

Mean cell haemoglobin concentration decreased (less concentration of haemoglobin in a given volume of packed red blood cells) is found to be associated with 316 drugs and 374 conditions by eHealthMe. Check the latest studies of Mean cell haemoglobin concentration decreased.



On Jul, 09, 2026

662,905 people reported to have side effects when taking Enbrel.
Among them, 22 people (0.0%) have Mean cell haemoglobin concentration decreased.

Could Enbrel cause Mean cell haemoglobin concentration decreased?

Among these 22 people:

How long have people been on Enbrel when they have Mean cell haemoglobin concentration decreased? *

  • < 1 month: 0.0 %
  • 1 - 6 months: 30 %
  • 6 - 12 months: 0.0 %
  • 1 - 2 years: 0.0 %
  • 2 - 5 years: 30 %
  • 5 - 10 years: 40 %
  • 10+ years: 0.0 %

What is the gender of people who have Mean cell haemoglobin concentration decreased when taking Enbrel? *

  • female: 86.36 %
  • male: 13.64 %

What is the age of people who have Mean cell haemoglobin concentration decreased when taking Enbrel? *

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 19.05 %
  • 20-29: 0.0 %
  • 30-39: 23.81 %
  • 40-49: 0.0 %
  • 50-59: 23.81 %
  • 60+: 33.33 %

What are other drugs people take besides Enbrel? *

  1. Arava: 5 people, 22.73%
  2. Actemra: 3 people, 13.64%
  3. Humira: 3 people, 13.64%
  4. Plaquenil: 2 people, 9.09%
  5. Prilosec: 2 people, 9.09%
  6. Lidoderm: 2 people, 9.09%
  7. Deltasone: 2 people, 9.09%
  8. Prograf: 2 people, 9.09%
  9. Remicade: 2 people, 9.09%
  10. Forteo: 1 person, 4.55%

What are other side effects people have besides Mean cell haemoglobin concentration decreased? *

  1. Haemoglobin Decreased: 17 people, 77.27%
  2. Mean Cell Volume Decreased (less of the average red blood cell volume): 10 people, 45.45%
  3. Mean Cell Haemoglobin Decreased (less than normal haemoglobin per red blood cell in a sample of blood): 10 people, 45.45%
  4. Haematocrit Decreased: 10 people, 45.45%
  5. Red Cell Distribution Width Increased: 10 people, 45.45%
  6. C-Reactive Protein Increased: 9 people, 40.91%
  7. Joint Pain: 7 people, 31.82%
  8. Eosinophil Count Increased: 6 people, 27.27%
  9. Platelet Count Increased: 6 people, 27.27%
  10. Lymphocyte Count Increased: 6 people, 27.27%

What are the existing conditions these people have? *

  1. Psoriasis (immune-mediated disease that affects the skin): 3 people, 13.64%
  2. Juvenile Rheumatoid Arthritis (joint inflammation in children due to systemic disease): 2 people, 9.09%
  3. Overdose: 1 person, 4.55%
  4. Osteoporosis (bones weak and more likely to break): 1 person, 4.55%
  5. Migraine (headache): 1 person, 4.55%
  6. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 1 person, 4.55%
  7. Gastric Ulcer (stomach ulcer): 1 person, 4.55%
  8. Chronic Recurrent Multifocal Osteomyelitis (rare condition (1:1,000,000), in which the bones have lesions, infection, and pain): 1 person, 4.55%
  9. Arthritis (form of joint disorder that involves inflammation of one or more joints): 1 person, 4.55%

* Approximation only. Some reports may have incomplete information.

Do you take Enbrel and have Mean cell haemoglobin concentration decreased?

- Check whether Mean cell haemoglobin concentration decreased is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, long term effects of, and alternative drugs to Enbrel:

Mean cell haemoglobin concentration decreased treatments and more:

How severe was Mean cell haemoglobin concentration decreased and when was it recovered:

Expand to all the drugs that have ingredients of etanercept:

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Enbrel:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Mean cell haemoglobin concentration decreased:

Browse all the conditions that are associated with Mean cell haemoglobin concentration decreased:


How the study uses the data?

The study uses data from the FDA. It is based on etanercept (the active ingredients of Enbrel) and Enbrel (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: